Literature DB >> 22798502

MGMT hypermethylation and MDR system in glioblastoma cancer stem cells.

Valentina Caldera1, Marta Mellai, Laura Annovazzi, Oriana Monzeglio, Angela Piazzi, Davide Schiffer.   

Abstract

BACKGROUND: Cancer stem cells (CSCs) in gliomas are associated with resistance to radio- and chemotherapy, based on O(6)-methylguanine-DNA methyltransferase (MGMT) hypermethylation and the Multidrug resistance (MDR) system activation.
MATERIALS AND METHODS: Samples from 21 glioblastomas (GBMs) were put in culture with growth factors or serum in order to obtain neurospheres or adherent cells. Both were genetically and immunohistochemically characterized for ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), ATP-binding cassette, sub-family C (CFTR/MRP), member 1 (ABCC1) and MGMT expression together with primary tumors.
RESULTS: ABCB1 expression was positive in endothelial cells of primary tumors. ABCC1 expression was variably positive in tumor cells and positive in neurospheres, and less expressed in adherent cells. MGMT was methylated and unmethylated in primary tumors and in neurospheres, respectively, and unmethylated in adherent cells.
CONCLUSION: Methylation is an epigenetic event affecting progenitors before the separation of the two glia lineages and maximally the future initiating cells. ABCB1 expression is limited to endothelial cells, whereas ABCC1 expression could mark a minority of tumor cells approaching a stem-like status.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798502

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  12 in total

1.  The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment.

Authors:  Laura Annovazzi; Valentina Caldera; Marta Mellai; Chiara Riganti; Luigi Battaglia; Daniela Chirio; Antonio Melcarne; Davide Schiffer
Journal:  Int J Oncol       Date:  2015-04-16       Impact factor: 5.650

2.  Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.

Authors:  So Mee Kwon; Shin-Hyuk Kang; Chul-Kee Park; Shin Jung; Eun Sung Park; Ju-Seog Lee; Se-Hyuk Kim; Hyun Goo Woo
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

3.  Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.

Authors:  Yanting Liu; Ningbo Xu; Boyang Liu; Yiru Huang; Huijun Zeng; Zhao Yang; Zhenyan He; Hongbo Guo
Journal:  Oncotarget       Date:  2016-07-12

4.  Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness.

Authors:  Zubeyde Erbayraktar; Begum Alural; Resat Serhat Erbayraktar; Erdogan Pekcan Erkan
Journal:  Cancer Cell Int       Date:  2016-11-18       Impact factor: 5.722

5.  Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma.

Authors:  Maria Consuelo Valentini; Marta Mellai; Laura Annovazzi; Antonio Melcarne; Tetyana Denysenko; Paola Cassoni; Cristina Casalone; Cristiana Maurella; Silvia Grifoni; Piercarlo Fania; Angelina Cistaro; Davide Schiffer
Journal:  Oncotarget       Date:  2017-10-04

6.  A peptide derived from apoptin inhibits glioma growth.

Authors:  Liqiu Zhang; Hengyu Zhao; Zhongqi Cui; Yueshan Lv; Wenjia Zhang; Xiaoyu Ma; Jianan Zhang; Banghao Sun; Danyang Zhou; Lijie Yuan
Journal:  Oncotarget       Date:  2017-05-09

Review 7.  Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma.

Authors:  Laura Annovazzi; Marta Mellai; Davide Schiffer
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

8.  Electrochemical affinity biosensors for fast detection of gene-specific methylations with no need for bisulfite and amplification treatments.

Authors:  Eloy Povedano; Eva Vargas; Víctor Ruiz-Valdepeñas Montiel; Rebeca M Torrente-Rodríguez; María Pedrero; Rodrigo Barderas; Pablo San Segundo-Acosta; Alberto Peláez-García; Marta Mendiola; David Hardisson; Susana Campuzano; José M Pingarrón
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

9.  Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.

Authors:  Hak-Bong Kim; Su-Hoon Lee; Jee-Hyun Um; Mi-Ju Kim; Suh-Kyung Hyun; Eun-Ji Gong; Won Keun Oh; Chi-Dug Kang; Sun-Hee Kim
Journal:  Int J Biol Sci       Date:  2015-06-11       Impact factor: 6.580

10.  Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma.

Authors:  Chin-Cheng Lee; Jin-Huei Lai; Dueng-Yang Hueng; Hsin-I Ma; Yuan- Chiang Chung; Ya-Yun Sun; Yih-Ju Tsai; Wen-Ben Wu; Chih-Li Chen
Journal:  Cancer Cell Int       Date:  2013-08-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.